Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C P Speer1

  • 1Universitäts-Kinderklinik Würzburg, Germany.

Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde
|April 1, 2020
PubMed
Summary
This summary is machine-generated.

Surfactant replacement therapy significantly improves outcomes for newborns with respiratory distress syndrome (RDS). Early treatment with natural surfactant preparations reduces complications and mortality, offering a major advancement in neonatal medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report.

BMC pediatrics·2019
Same author

Outbreak of multidrug-resistant Escherichia coli sequence type 131 in a neonatal intensive care unit: efficient active surveillance prevented fatal outcome.

The Journal of hospital infection·2016
Same author

[Lung Function in Childhood and Adolescence: Influence of Prematurity and Bronchopulmonary Dysplasia].

Zeitschrift fur Geburtshilfe und Neonatologie·2016
Same author

Late Vitamin K Deficient Bleeding in 2 Young Infants--Renaissance of a Preventable Disease.

Zeitschrift fur Geburtshilfe und Neonatologie·2015
Same author

[European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2014
Same author

An 8-month history of meningitis in an extremely low birth weight infant? - Long-lasting Infection with Ureaplasma parvum.

Zeitschrift fur Geburtshilfe und Neonatologie·2014
Same journal

[The COVID-19 pandemic-How did it affect the mental health of children?]

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[COVID-19 vaccination in children and adolescents].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Prevalence of post-COVID-19 in nonhospitalized adolescents and young adults].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Education and education deficits in day care centers and schools during the coronavirus pandemic].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Learning deficits in the COVID-19 pandemic].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
Same journal

[Pediatrics up to date-Brief notes on research].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·2023
See all related articles

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Biochemistry

Context:

  • Neonatal respiratory distress syndrome (RDS) is a significant cause of mortality and morbidity in newborns.
  • The surfactant system plays a critical role in lung function and can be impaired in various neonatal pulmonary diseases.
  • Surfactant replacement therapy has emerged as a key intervention in neonatal care.

Purpose:

  • To evaluate the efficacy of surfactant replacement therapy in neonatal respiratory distress syndrome (RDS).
  • To compare the outcomes of natural versus synthetic surfactant preparations.
  • To explore the potential benefits of surfactant therapy in other neonatal lung conditions.

Summary:

  • Surfactant replacement therapy, either as prophylaxis or treatment for RDS, reduces air leaks and mortality, leading to better long-term lung health in neonates.
Keywords:
Keywords Preterm infantsProphylaxisPulmonary surfactantRescueResspiratory distress syndrome

Related Experiment Videos

  • Early administration of surfactant is associated with improved outcomes.
  • Natural surfactant preparations demonstrate a consistent advantage over synthetic ones in meta-analyses.
  • Dosing recommendations include an initial 100 mg/kg for natural preparations, with potential benefits from multiple doses.
  • Emerging evidence suggests surfactant therapy may also benefit conditions like meconium aspiration syndrome and neonatal pneumonia.

    • Impact:

    • Improved survival rates for infants with RDS.
    • Reduced incidence of chronic lung disease in surviving neonates.
    • Potential for broader application of surfactant therapy in other neonatal respiratory conditions.